47 filings
Page 2 of 3
8-K
kt6sjf6c0863h 6s
13 Jul 22
Royalty Pharma Agrees to Acquire Royalty Interest In Trelegy
4:34pm
8-K
ay80w 6gnivq5
23 Jun 22
Submission of Matters to a Vote of Security Holders
5:13pm
8-K
ixgw29y
17 May 22
Royalty Pharma Investor Day Highlights Stronger Growth Outlook and the Power of Its Unique Business Model to Drive Value for All Stakeholders
7:37am
8-K
x43l8hbf
11 May 22
Other Events
11:32am
8-K
f7z9nlt l9s57la
5 May 22
Results of Operations and Financial Condition
7:37am
8-K
35qm m0qhh
15 Apr 22
Other Events
4:22pm
8-K
q1535c4f
4 Apr 22
Changes in Registrant's Certifying Accountant
4:57pm
8-K
pz7ha28b
15 Feb 22
Results of Operations and Financial Condition
7:55am
8-K
dt4zkkl7e 0zdk0ph
10 Jan 22
Royalty Pharma Highlights Accomplishments and Provides Business Update at 40TH Annual J.P. Morgan Healthcare Conference
7:37am
8-K
8j5ra
10 Nov 21
Results of Operations and Financial Condition
7:59am
8-K
3b6zt7zgtgwd8qy46s
11 Aug 21
Results of Operations and Financial Condition
7:47am
8-K
cuh4zy21 bst
26 Jul 21
Entry into a Material Definitive Agreement
5:00pm
8-K
y7l6odwa4rqkg l3
16 Jul 21
Entry into a Material Definitive Agreement
5:11pm
8-K
k4m3b 1q0vx
25 Jun 21
Submission of Matters to a Vote of Security Holders
5:21pm
8-K
jorvau2enlwwm5 qs358
2 Jun 21
Royalty Pharma Announces $2.025 Billion Strategic Funding Partnership with Morphosys
7:51am
8-K
098ks1n3nliiw4n
11 May 21
Results of Operations and Financial Condition
7:57am
8-K
nn0gzz xps2
17 Feb 21
Royalty Pharma Reports Q4 2020 and Full-year Results
7:16am
8-K
28nax8os
3 Feb 21
Other Events
8:22am
8-K
476t0
10 Nov 20
Royalty Pharma Reports Third Quarter 2020 Results
5:16pm
8-K
r10y bsp03l
5 Nov 20
Entry into a Material Definitive Agreement
4:40pm